Delivery Order SPE2DB22D3301-SPE2DB24FZ3UL
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,161 units of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-count packages. The $5,193.06 delivery order has a performance period through April 9, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) has awarded a $2,596.53 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564107047 - VEMLIDY 25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop...
The Defense Logistics Agency (DLA) has awarded a $10,445.23 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET UU 30S. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product VEMLIDY 25 MG TABLET UU 30S. The contract has a ceiling value of $5,754.35 and a period of performance through April 4, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a total potential value of up to...
The Defense Logistics Agency (DLA) has awarded a $5,193.06 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET medical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
The Defense Logistics Agency (DLA) awarded a $6,231.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of VEMLIDY 25 MG TABLET medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEMLIDY 25 MG TABLET medication. The $7,789.59 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,744.10 firm fixed price contract is for the supply of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-tablet units. The order has an ultimate completion date of August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a...
This is a $2,693.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 27, 2024. The order is for the supply of VEMLIDY 25 MG TABLET, a prescription medication, to support DLA's mission to provide medical commodities to military treatment facilities and other government healthcare providers. The contract has an ultimate completion date of August 28, 2024 and does not utilize a small...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $3,334.11 order has a completion date of February 7, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...